id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1975-N-0012-0025,FDA,FDA-1975-N-0012,"Tab E - ""Alcavis International, Inc., Letter to FDA, March 18, 2003"" - [Alcavis, International, Inc., (Buchanan Ingerson and Rooney PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T20:35:48Z,,0,0,0900006480a4d2b1
FDA-1975-N-0012-0033,FDA,FDA-1975-N-0012,"Tab M - ""Alcavis International, Inc. (Alston & Bird, LLP) Letter to FDA, October 4, 2006"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T20:57:54Z,,0,0,0900006480a4d4e9
FDA-1975-N-0012-0029,FDA,FDA-1975-N-0012,"Tab I - ""Alcavis International, Inc. Letter to FDA, July 1, 2003"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T20:51:54Z,,0,0,0900006480a4d497
FDA-1975-N-0012-0028,FDA,FDA-1975-N-0012,"Tab H - ""Alcavis International, Inc. Letter to FDA, June 17, 2003"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T20:50:56Z,,0,0,0900006480a4d459
FDA-1975-N-0012-0027,FDA,FDA-1975-N-0012,"Tab G - ""Alcavis International, Inc. Letter to FDA, June 5, 2003"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T20:50:16Z,,0,0,0900006480a4d355
FDA-1975-N-0012-0024,FDA,FDA-1975-N-0012,"Tab D - ""Alcavis International, Inc., Letter to FDA, December 20, 2002"" - [Alcavis, International, Inc., (Buchanan Ingerson and Rooney PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T20:34:25Z,,0,0,0900006480a4d2af
FDA-1975-N-0012-0036,FDA,FDA-1975-N-0012,"Index of Select Scientific References Cited - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC) - Request for Hearing]  re FDA-1975-N-0013-0018",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-10-27T17:29:30Z,,0,0,0900006480a6f8fa
FDA-1975-N-0012-0034,FDA,FDA-1975-N-0012,"Tab N - ""Alcavis International, Inc. (Alston & Bird, LLP) Supplement, February 6, 2009"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T21:00:16Z,,0,0,0900006480a4d7b5
FDA-1975-N-0012-0021,FDA,FDA-1975-N-0012,"Tab A - Citizen Petition Filed by Robert G. Pinco, Akin, Gump, Strauss, Hauer & Feld, January 29, 1999 - (Alcavis, International, Inc., (Buchanan Ingerson and Rooney PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T20:31:45Z,,0,0,0900006480a4d24e
FDA-1975-N-0012-0023,FDA,FDA-1975-N-0012,"Tab C - ""FDA Response to Alcavis International, Inc., November 14, 2002"" - [Alcavis, International, Inc., (Buchanan Ingerson and Rooney PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T20:33:42Z,,0,0,0900006480a4d2ac
FDA-1975-N-0012-0035,FDA,FDA-1975-N-0012,"Tab O - ""FDA/CDER Response to Alcavis International, Inc. - Petition Denial, April 24, 2009"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T21:01:01Z,,0,0,0900006480a4d7b6
FDA-1975-N-0012-0022,FDA,FDA-1975-N-0012,"Tab B - ""Citizen Petition Filed by Alcavis, International, Inc., Feburary 20, 2002"" - [Alcavis, International, Inc., (Buchanan Ingerson and Rooney PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T20:32:56Z,,0,0,0900006480a4d252
FDA-1975-N-0012-0026,FDA,FDA-1975-N-0012,"Tab F - ""68 Federal Register 32003 Dated May 29, 2003"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T20:38:00Z,,0,0,0900006480a4d350
FDA-1975-N-0012-0031,FDA,FDA-1975-N-0012,"Tab K - ""Alcavis International, Inc. Letter to FDA, March 15, 2004"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T20:55:21Z,,0,0,0900006480a4d4e6
FDA-1975-N-0012-0030,FDA,FDA-1975-N-0012,"Tab J - ""Alcavis International, Inc. Letter to FDA, February 10, 2004"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T20:52:26Z,,0,0,0900006480a4d4e4
FDA-1975-N-0012-0032,FDA,FDA-1975-N-0012,"Tab L - ""Alcavis International, Inc. (Alston & Bird, LLP) Letter to FDA, July 15, 2005"" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)",Supporting & Related Material,Background Material,2009-12-22T05:00:00Z,2009,12,,,2017-11-29T20:56:35Z,,0,0,0900006480a4d4e7
FDA-1975-N-0012-0020,FDA,FDA-1975-N-0012,See FDA-1975-N-0012-0019,Supporting & Related Material,Background Material,2009-10-26T04:00:00Z,2009,10,,,2014-01-05T03:25:07Z,,0,0,0900006480a4c2d3
FDA-1975-N-0012-0019,FDA,FDA-1975-N-0012,Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Health-Care Antiseptic Drug Products; Reopening of the Administrative Record,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2009-10-26T04:00:00Z,2009,10,2003-05-29T04:00:00Z,2003-08-28T03:59:59Z,2017-11-28T15:24:53Z,03-13317,0,0,09000064805c1b5f
FDA-1975-N-0012-0018,FDA,FDA-1975-N-0012,Petition Denial Response Letter from FDA to Alcavis International,Other,Denial of Petition,2009-04-24T04:00:00Z,2009,4,2009-04-24T04:00:00Z,2019-04-04T03:59:59Z,2018-04-03T19:26:43Z,,0,0,09000064809693f7
FDA-1975-N-0012-0017,FDA,FDA-1975-N-0012,"Letter from Alcavis International Inc. (Alston & Bird, LLP)  to FDA - July 15, 2005",Other,Letter(s),2009-03-04T05:00:00Z,2009,3,2009-03-04T05:00:00Z,,2017-10-27T19:14:39Z,,0,0,09000064808ea11c
FDA-1975-N-0012-0016,FDA,FDA-1975-N-0012,"Letter from Alcavis International Inc. (Buchanan Ingersoll) to FDA - February 10, 2004",Other,Letter(s),2009-03-04T05:00:00Z,2009,3,2009-03-04T05:00:00Z,,2017-10-27T19:13:26Z,,0,0,09000064808ea0a0
FDA-1975-N-0012-0015,FDA,FDA-1975-N-0012,"Alcavis HDC, LLC (Alston & Bird, LLP) - Supplement re CP13",Other,Supplement (SUP),2009-02-10T05:00:00Z,2009,2,2009-02-10T05:00:00Z,,2014-01-05T03:25:07Z,,0,0,090000648084a308